We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
Turnover
9.3%
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
+15.18%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$46.2B
AUM Growth
+$4.02B
(+9.6%)
Cap. Flow
-$2.06B
Cap. Flow
% of AUM
-4.46%
Top 10 Holdings %
Top 10 Hldgs %
19.65%
Holding
934
New
52
Increased
488
Reduced
320
Closed
33
Avg Time Held
1.3
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$191M |
| 2 |
Microsoft
MSFT
|
+$169M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$162M |
| 4 |
Netflix
NFLX
|
+$126M |
| 5 |
Philip Morris
PM
|
+$87.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$231M |
| 2 |
Banco Bradesco
BBD
|
+$182M |
| 3 |
Amdocs
DOX
|
+$175M |
| 4 |
Oracle
ORCL
|
+$156M |
| 5 |
Chevron
CVX
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.31% |
| 2 | Technology | 14.86% |
| 3 | Consumer Discretionary | 13.47% |
| 4 | Healthcare | 10.93% |
| 5 | Communication Services | 10.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Merck
MRK
$358B
| $251M | 0.54% |
3,165,724
-159,822
| -5% | -$12M |
2017 Q3
6 quarters
|
|
52
Mondelez International
MDLZ
$80.4B
| $250M | 0.54% |
5,000,824
-902,498
| -15% | -$41.4M |
2017 Q3
6 quarters
|
|
53
Home Depot
HD
$308B
| $249M | 0.54% |
1,297,422
-173,514
| -12% | -$31.8M |
2017 Q3
6 quarters
|
|
|
54
Pfizer
PFE
$168B
| $243M | 0.53% |
6,020,058
-5,770,957
| -49% | -$231M |
2017 Q3
6 quarters
|
|
55
DuPont de Nemours
DD
$17.8B
| $240M | 0.52% |
1,774,693
-480,709
| -21% | -$66.7M |
2017 Q3
6 quarters
|
|
56
Intel
INTC
$504B
| $235M | 0.51% |
4,371,354
+152,734
| +4% | +$7.75M |
2017 Q3
6 quarters
|
|
57
JPMorgan Chase
JPM
$891B
| $233M | 0.5% |
2,298,892
+260,201
| +13% | +$26.8M |
2017 Q3
6 quarters
|
|
58
Charles Schwab
SCHW
$163B
| $222M | 0.48% |
5,184,539
+665,391
| +15% | +$30M |
2017 Q3
6 quarters
|
|
59
Marvell Technology
MRVL
$217B
| $216M | 0.47% |
10,876,059
-734,165
| -6% | -$13.7M |
2018 Q1
4 quarters
|
|
60
Medtronic
MDT
$122B
| $207M | 0.45% |
2,273,737
-1,184,526
| -34% | -$106M |
2017 Q3
6 quarters
|
|
|
61
Linde
LIN
$227B
| $203M | 0.44% |
+1,152,668
| New | +$191M |
2019 Q1
0 quarters
|
|
62
Deere & Co
DE
$175B
| $198M | 0.43% |
1,241,548
-106,336
| -8% | -$17M |
2017 Q3
6 quarters
|
|
63
CME Group
CME
$104B
| $198M | 0.43% |
1,201,826
-255,180
| -18% | -$45.1M |
2017 Q3
6 quarters
|
|
|
64
Netflix
NFLX
$302B
| $194M | 0.42% |
5,436,850
+3,628,470
| +201% | +$126M |
2017 Q3
6 quarters
|
|
65
Procter & Gamble
PG
$365B
| $191M | 0.41% |
1,831,694
+159,351
| +10% | +$15.5M |
2017 Q3
6 quarters
|
|
66
Restaurant Brands International
QSR
$25.8B
| $189M | 0.41% |
2,901,309
-631,425
| -18% | -$38.8M |
2018 Q1
4 quarters
|
|
|
67
Bristol-Myers Squibb
BMY
$124B
| $189M | 0.41% |
3,953,089
+3,259,004
| +470% | +$162M |
2017 Q3
6 quarters
|
|
68
Berkshire Hathaway Class B
BRK.B
$1.13T
| $182M | 0.39% |
905,296
+27,443
| +3% | +$5.54M |
2017 Q3
6 quarters
|
|
69
M&T Bank
MTB
$31.6B
| $180M | 0.39% |
1,148,977
-101,949
| -8% | -$16.7M |
2017 Q3
6 quarters
|
|
70
Burlington
BURL
$16.8B
| $178M | 0.39% |
1,136,684
+470,242
| +71% | +$75.8M |
2017 Q3
6 quarters
|
|
71
CSX Corp
CSX
$90.2B
| $176M | 0.38% |
7,037,238
-5,727,408
| -45% | -$133M |
2017 Q3
6 quarters
|
|
72
Coca-Cola
KO
$396B
| $171M | 0.37% |
3,642,494
+582,317
| +19% | +$27.2M |
2017 Q3
6 quarters
|
|
73
Celanese
CE
$5.1B
| $170M | 0.37% |
1,724,240
-387,587
| -18% | -$38.1M |
2017 Q3
6 quarters
|
|
74
Check Point Software Technologies
CHKP
$14.1B
| $169M | 0.37% |
1,332,822
-304,194
| -19% | -$35.4M |
2017 Q3
6 quarters
|
|
75
TSMC
TSM
$2.19T
| $157M | 0.34% |
3,839,670
-643,855
| -14% | -$24.6M |
2017 Q3
6 quarters
|
|
Similar funds
Aberdeen Group's Q1 2019 Portfolio in Review
As of Q1 2019, Aberdeen Group held 934 positions worth $46.2B, up 9.6% from $42.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Aberdeen Group withdrew a net $2.06B in Q1 2019, closing 33 positions and reducing 320 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $36M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Aberdeen Group opened a new position in Linde worth $203M.
- Aberdeen Group's largest Q1 2019 buy was Linde: 1,152,668 shares worth $203M.
- Aberdeen Group added most to Microsoft in Q1 2019, an estimated $169M increase.
- Aberdeen Group's biggest Q1 2019 reduction was Pfizer, cutting an estimated $231M.
- Aberdeen Group fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $36M.
- Aberdeen Group's ten largest holdings make up 20% of its $46.2B portfolio in Q1 2019.
- Aberdeen Group opened 52 new positions and closed 33 in Q1 2019.
- Aberdeen Group's portfolio value rose 9.6% quarter-over-quarter to $46.2B.
Based on Aberdeen Group's 13F filing for Q1 2019, filed 14 May 2019.